Jason Lettmann

Affiliations

  • Chief Executive Officer at Alx Oncology Holdings Inc (ALXO), 2024-03-18
  • Large Shareholder, Director at Ra Pharmaceuticals Inc. (RARX), 2017-06-22
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ALXO $11.31 4,400 171,620 2024-03-14 Filing
ALXO $19.00 22,000 Large Shareholder, Director 22,000 2020-07-21 Filing
ALXO $19.00 378,000 Large Shareholder, Director 378,000 2020-07-21 Filing
RARX $13.00 15,633 Director 4,066,503 2016-10-31 Filing
RARX $13.00 114,752 Director 4,050,870 2016-10-31 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ALXO $30.23 60 Large Shareholder, Director 285,956 2021-12-13 Filing
ALXO $30.23 440 Large Shareholder, Director 2,097,326 2021-12-13 Filing
ALXO $29.60 181 Large Shareholder, Director 286,016 2021-12-13 Filing
ALXO $29.60 1,329 Large Shareholder, Director 2,097,766 2021-12-13 Filing
ALXO $28.37 299 Large Shareholder, Director 286,197 2021-12-13 Filing